Skip to content

US · UFPT · MEDICAL - DEVICES

UFP Technologies, Inc. (UFPT) intrinsic value and stock valuation

$290.85as of 2026-11-21 · Mkt cap 2.49B

Data updated · price as of 2026-11-21

OvervaluedIC value is 20–50% below the price. The exact IC value, upside and the fair-value band are available with Pro.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

UFP Technologies, Inc. DCF and intrinsic value

InvestorsCraft values UFPT with the Chepakovich two-stage DCF model — currently rated overvalued. How the model works · Run your own DCF prefilled from UFPT’s statements →

UFP Technologies, Inc. Graham Number

Graham Number: $104.76d — the price is above the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →

Healthcare · Medical - Devices Newburyport, MA 01950-3504 ufpt.com

How the business is doing

Fiscal 2011–2025, USD

Revenue
$602.8M+27.4% 5y CAGRd
20112025
Net income
$68.3M+38.6% 5y CAGRd
20112025
Free cash flow
$79M+30.7% 5y CAGRd
20112025
Total equity
$423.9M+19.1% 5y CAGRd
20112025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2011–2025, USD
20252024202320222021
Revenue$602.8M$504.4M$400.1M$353.8M$206.3M
Operating income$92.3M$80.9M$57.7M$55.4M$21.2M
Net income$68.3M$59M$44.9M$41.8M$15.9M
EPSd$8.76M$7.57M$5.83M$5.46M$2.09M
Operating cash flow$91.9M$66.6M$41.3M$17.7M$14.3M
Capital expenditure-$-12.93M-$-9.66M-$-10.49M-$-13.78M-$-5.39M
Free cash flow$79M$56.9M$30.8M$3.96M$8.9M
Total assets$665.7M$629M$404.1M$378.2M$334.1M
Total debt$154.5M$206M$46M$68.4M$84.4M
Net debt$134.2M$192.6M$40.8M$63.9M$73.2M
Total equity$423.9M$342.8M$286.1M$237.5M$194.5M
Cash and short-term investments$20.3M$13.5M$5.26M$4.45M$11.1M
Income statement
20252024202320222021
Revenue$602.8M$504.4M$400.1M$353.8M$206.3M
Cost of revenue$432.4M$357.7M$287.9M$263.5M$155.2M
Gross profit$170.4M$146.7M$112.2M$90.3M$51.1M
Research and development expenses$0.00$0.00$0.00$0.00$0.00
Selling, general and administrative expenses$77.4M$62.2M$50.9M$45.8M$29.5M
Other expenses$630K$3.58M$3.67M-$-10.94M$420K
Operating expenses$78.1M$65.8M$54.6M$34.9M$29.9M
Cost and expenses$510.5M$423.5M$342.4M$298.4M$185.1M
Interest income$0.00$0.00$0.00$0.00$50K
Interest expense$9.8M$8.06M$3.65M$2.76M$40K
Depreciation and amortization$23.4M$14.7M$11.4M$11.9M$8.41M
Ebitda$115.7M$95.8M$69M$67.4M$29.7M
Operating income$92.3M$80.9M$57.7M$55.4M$21.2M
Total other income/expenses, net-$-9.82M-$-7.87M-$-3.76M-$-2.68M-$-10K
Income before tax$82.5M$73M$53.9M$52.7M$21.2M
Income tax expense$14.2M$14M$8.98M$10.9M$5.32M
Net income$68.3M$59M$44.9M$41.8M$15.9M
Weighted average shares outstanding$7.71M$7.67M$7.62M$7.56M$7.52M
Weighted average diluted shares outstanding$7.8M$7.79M$7.7M$7.66M$7.62M
Balance sheet
20252024202320222021
Cash and short-term investments$20.3M$13.5M$5.26M$4.45M$11.1M
Net receivables$88.2M$89.7M$65.8M$55.1M$39.4M
Inventory$86.9M$87.5M$70.2M$53.5M$33.4M
Total current assets$201M$194.9M$144.6M$116.4M$87.3M
Property, plant and equipment, net$98M$86.7M$75.7M$71.2M$65.9M
Goodwill and intangible assets$338.3M$333.9M$177.4M$181.4M$175.5M
Long-term investments$6.93M$6.81M$0.00$0.00$0.00
Total non-current assets$464.7M$434.1M$259.5M$261.9M$246.8M
Total assets$665.7M$629M$404.1M$378.2M$334.1M
Accounts payable$24.3M$24.3M$22.3M$20M$10.6M
Short-term debt$17.5M$16.7M$7.22M$6.52M$6.24M
Deferred revenue$4.24M$4.67M$6.62M$4.68M$4.25M
Total current liabilities$74.9M$76.3M$58.2M$56M$38.8M
Long-term debt$136.9M$189.3M$38.8M$61.9M$78.1M
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$167M$209.9M$59.8M$84.7M$100.9M
Capital lease obligations$19M$16.7M$14M$13.4M$9.36M
Total liabilities$241.9M$286.2M$118.1M$140.7M$139.7M
Common stock$80K$80K$80K$80K$70K
Retained earnings$374.8M$306.5M$247.5M$202.6M$160.8M
Accumulated other comprehensive income (loss)$3.71M-$-4.17M$270K-$-610K$0.00
Total equity$423.9M$342.8M$286.1M$237.5M$194.5M
Total investments$6.93M$6.81M$0.00$0.00$0.00
Total debt$154.5M$206M$46M$68.4M$84.4M
Net debt$134.2M$192.6M$40.8M$63.9M$73.2M
Cash flow statement
20252024202320222021
Net income$68.3M$59M$44.9M$41.8M$15.9M
Depreciation and amortization$19.2M$14.7M$11.4M$11.9M$8.41M
Stock-based compensation$8.85M$6.84M$4.64M$3.21M$2.43M
Change in working capital-$-9.7M-$-16.34M-$-24.13M-$-22.47M-$-10.62M
Accounts receivable$4.79M-$-2.19M-$-12.11M-$-15.91M-$-6.86M
Inventory$3.9M-$-4.69M-$-16.57M-$-19.61M-$-4.5M
Accounts payable-$-1.09M-$-1.14M$1.55M$9.13M$100K
Net cash provided by operating activities$91.9M$66.6M$41.3M$17.7M$14.3M
Investments in property, plant and equipment-$-12.93M-$-9.66M-$-10.49M-$-13.78M-$-5.39M
Acquisitions, net-$-14.72M-$-197.48M$0.00-$-20.65M-$-96.18M
Net cash used for investing activities-$-27.6M-$-210.16M-$-10.49M$1.29M-$-101.46M
Common stock issued$190K-$-4.72M$680K$0.00$0.00
Common stock repurchased$0.00$0.00$0.00$0.00$0.00
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities-$-58.16M$152.4M-$-30.02M-$-25.89M$74.1M
Net change in cash$6.85M$8.19M$810K-$-6.67M-$-13.12M
Cash at end of period$20.3M$13.5M$5.26M$4.45M$11.1M
Operating cash flow$91.9M$66.6M$41.3M$17.7M$14.3M
Capital expenditure-$-12.93M-$-9.66M-$-10.49M-$-13.78M-$-5.39M
Free cash flow$79M$56.9M$30.8M$3.96M$8.9M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About UFP Technologies, Inc.

        UFP Technologies, Inc. specializes in the engineering and custom fabrication of components, subassemblies, finished products, and packaging, primarily utilizing advanced foams, films, and plastics. A significant portion of its business is dedicated to the medical sector, where its single-use and single-patient devices and parts are integral to a broad spectrum of applications, including general medical devices, disposable wound care, infection control, minimally invasive surgical tools, wearable technologies, orthopedic soft goods, and protective packaging for orthopedic implants. Beyond healthcare, the company extends its expertise to the automotive, aerospace and defense, consumer, electronics, and industrial markets. Here, its engineered products and components are incorporated into diverse items such as military uniform and gear, automotive interior trim, athletic padding, sustainable protective packaging, air filtration systems, abrasive nail files, and custom protective cases and inserts. UFP Technologies markets and distributes its offerings across the United States, predominantly through a direct sales force supported by independent manufacturer representatives. The company, established in 1963, is headquartered in Newburyport, Massachusetts.

        CEO
        Mitchell C. Rock
        Employees
        4.85K
        Beta
        1.07

        Explore

        Frequently asked questions

        What is the intrinsic value of UFP Technologies, Inc. (UFPT)?

        UFP Technologies, Inc. (UFPT) is currently overvalued based on the InvestorsCraft IC model — IC value is 20–50% below the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.

        Is UFPT undervalued?

        UFPT trades at a price of $290.85 (Nov 21, 2026): overvalued — IC value is 20–50% below the price.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.